Long-term functional benefits of Epicardial patches as cell carriers

Cell Transplantation

Volumn 23, Issue 1, 2014, Pages 87-96

  Hamdi, Hadhami ^a   Planat Benard, Valérie ^b   Bel, Alain ^a,c   Neamatalla, Hany ^a,c   Saccenti, Laetitia ^a   Calderon, Damelys ^a   Bellamy, Valérie ^a   Bon, Martin ^a   Perrier, Marie Cécile ^d   Mandet, Chantal ^c   Bruneval, Patrick ^c   Casteilla, Louis ^b   Hagège, Albert A ^a,c   Pucéat, Michel ^a   Agbulut, Onnik ^e   Menasché, Philippe ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Adipose derived stromal cells (ADSCs); Cardiac patches; Cardiovascular progenitors; Cell therapy; Embryonic stem cells (ESCs); Stage specific embryonic antigen 1 positive (SSEA 1+) cells

Indexed keywords

STAGE SPECIFIC EMBRYO ANTIGEN 1;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR THERAPEUTIC DEVICE; CELL THERAPY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBRYONIC STEM CELL; EPICARDIAL COLLAGEN PATCH; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; RAT; STROMA CELL;

ADIPOSE TISSUE; ANIMALS; CELL- AND TISSUE-BASED THERAPY; COLLAGEN; DEFIBRILLATORS, IMPLANTABLE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; PERICARDIUM; RATS; RATS, WISTAR; TISSUE SCAFFOLDS;

EID: 84892581469     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X658836     Document Type: Article

References (33)

1. Bel, A.; Planat-Bernard, V.; Saito, A.; Bonnevie, L.; Bellamy, V.; Sabbah, L.; Bellabas, L.; Brinon, B.; Vanneaux, V.; Pradeau, P.; Peyrard, S.; Larghero, J.; Pouly, J.; Binder, P.; Garcia, S.; Shimizu, T.; Sawa, Y.; Okano, T.; Bruneval, P.; Desnos, M.; Hagège, A. A.; Casteilla, L.; Pucéat, M.; Menasché, P. Composite cell sheets: A further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 122:S118-S123; 2010.
2. Blin, G.; Nury, D.; Stefanovic, S.; Neri, T.; Guillevic, O.; Brinon, B.; Bellamy, V.; Rücker-Martin, C.; Barbry, P.; Bel, A.; Bruneval, P.; Cowan, C.; Pouly, J.; Mitalipov, S.; Gouadon, E.; Binder, P.; Hagège, A.; Desnos, M.; Renaud, J.-F.; Menasché, P.; Pucéat, M. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J. Clin. Invest. 120:1125-1139; 2010.
3. Bolli, R.; Chugh, A. R.; D'Amario, D.; Loughran, J. H.; Stoddard, M. F.; Ikram, S.; Beache, G. M.; Wagner, S. G.; Leri, A.; Hosoda, T.; Sanada, F.; Elmore, J. B.; Goichberg, P.; Cappetta, D.; Solankhi, N. K.; Fahsah, I.; Rokosh, D. G.; Slaughter, M. S.; Kajstura, J.; Anversa, P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 378:1847-1857; 2011.
4. Bonaros, N.; Rauf, R.; Wolf, D.; Margreiter, E.; Tzankov, A.; Schlechta, B.; Kocher, A.; Ott, H.; Schachner, T.; Hering, S.; Bonatti, J.; Laufer, G. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure. J. Thorac. Cardiovasc. Surg. 132:1321-1328; 2006.
5. Calderon, D.; Planat-Benard, V.; Bellamy, V.; Vanneaux, V.; Khun, C.; Peyrard, S.; Larghero, J.; Desnos, M.; Casteilla, L.; Pucéat, M.; Menasché, P.; Chatenoud, L. Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells. J. Cell. Mol. Med. 16:1544-1552; 2012.
6. Christman, K. L.; Vardanian, A. J.; Fang, Q.; Sievers, R. E.; Fok, H. H.; Lee, R. J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44:654-660; 2004.
7. Crisostomo, P. R.; Crisostomo, P. R.; Abarbanell, A. M.; Wang, M.; Lahm, T.; Wang, Y.; Meldrum, D. R. Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. Am. J. Physiol. Heart Circ. Physiol. 295(4):H1726-H1735; 2008.
8. Fairchild, P. J. The challenge of immunogenicity in the quest for induced pluripotency. Nat. Rev. Immunol. 10:868-875; 2010.
9. Godier-Furnémont, A. F. G.; Martens, T. P.; Koeckert, M. S.; Wan, L.; Parks, J.; Arai, K.; Zhang, G.; Hudson, B.; Homma, S.; Vunjak-Novakovic, G. Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc. Natl. Acad. Sci. USA 108:7974-7979; 2011.
10. Hamdi, H.; Furuta, A.; Bellamy, V.; Bel, A.; Puymirat, E.; Peyrard, S.; Agbulut, O.; Menasché, P. Cell delivery: Intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann. Thorac. Surg. 87:1196-1203; 2009.
11. Hamdi, H.; Planat-Benard, V.; Bel, A.; Puymirat, E.; Geha, R.; Pidial, L.; Nematalla, H.; Bellamy, V.; Bouaziz, P.; Peyrard, S.; Casteilla, L.; Bruneval, P.; Hagège, A. A.; Agbulut, O.; Menasché, P. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc. Res. 91:483-491; 2011.
12. Hoogduijn, M. J.; Crop, M. J.; Korevaar, S. S.; Peeters, A. M. A.; Eijken, M.; Maat, L. P. W. M.; Balk, A. H. M. M.; Weimar, W.; Baan, C. C. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. Transplantation 86:1283-1291; 2008.
13. Imanishi. Y.; Migayawa, S.; Maeda, N.; Fukushima, S.; Kitagawa-Sakakida, S.; Daimon, T.; Hirata, A.; Shimizu, T.; Okano, T.; Shimomura, I.; Sawa, Y. Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: A novel drug delivery system for heart failure. Circulation 124:S10-S17; 2011.
14. Landa, N.; Miller, L.; Feinberg, M. S.; Holbova, R.; Shachar, M.; Freeman, I.; Cohen, S.; Leor, J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117:1388-1396; 2008.
15. Li, T. S.; Takahashi, M.; Ohshima, M.; Qin, S. L.; Kubo, M.; Muramatsu, K.; Hamano, K. Myocardial repair achieved by the intramyocardial implantation of adult cardiomyocytes in combination with bone marrow cells. Cell Transplant. 17:695-703; 2008.
16. Li, W.; Ren, G.; Huang, Y.; Su, J.; Han, Y.; Li, J.; Chen, X.; Cao, K.; Chen, Q.; Shou, P.; Zhang, L.; Yuan, Z. R.; Roberts, A. I.; Shi, S.; Le, A. D.; Shi, Y. Mesenchymal stem cells: A double-edged sword in regulating immune responses. Cell Death Differ. 19(9):1505-1513; 2012.
17. Masumoto, H.; Matsuo, T.; Yamamizu, K.; Uosaki, H.; Narazaki, G.; Katayama, S.; Marui, A.; Shimizu, T.; Ikeda, T.; Okano, T.; Sakata, R.; Yamashita, J. K. Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization. Stem Cells 30(6):1196-1205; 2012.
18. Matsuura, K.; Honda, A.; Nagai, T.; Fukushima, N.; Iwanaga, K.; Tokunaga, M.; Shimizu, T.; Okano, T.; Kasanuki, H.; Hagiwara, N.; Komuro, I. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J. Clin. Invest. 119:2204-2217; 2009.
19. Matsuura, K.; Masuda, S.; Haraguchi, Y.; Yasuda, N.; Shimizu, T.; Hagiwara, N.; Zandstra, P. W.; Okano, T. Creation of mouse embryonic stem cell-derived cardiac cell sheets. Biomaterials 32:7355-7362; 2011.
20. Mokashi, S. A.; Guan, J.; Wang, D.; Tchantchaleishvili, V.; Brigham, M.; Lipsitz, S.; Lee, L. S.; Schmitto, J. D.; Bolman, 3rd, R. M.; Khademhosseini, A.; Liao, R.; Chen, F. Y. Preventing cardiac remodeling: The combination of cell-based therapy and cardiac support therapy preserves left ventricular function in rodent model of myocardial ischemia. J. Thorac. Cardiovasc. Surg. 140:1374-1380; 2010.
21. Nelson, D. M.; Ma, Z.; Fujimoto, K. L.; Hashizume, R.; Wagner, W. R. Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater. 7:1-15; 2011.
22. Planat-Benard, V.; Silvestre, J.-S.; Cousin, B.; André, M.; Nibbelink, M.; Tamarat, R.; Clergue, M.; Manneville, C.; Saillan-Barreau, C.; Duriez, M.; Tedgui, A.; Levy, B.; Pénicaud, L.; Casteilla, L. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 109:656-663; 2004.
23. Pouly, J.; Bruneval, P.; Mandet, C.; Proksch, S.; Peyrard, S.; Amrein, C.; Bousseaux, V.; Guillemain, R.; Deloche, A.; Fabiani, J.-N.; Menasché, P. Cardiac stem cells in the real world. J. Thorac. Cardiovasc. Surg. 135:673-678; 2008.
24. Puymirat, E.; Geha, R.; Tomescot, A.; Bellamy, V.; Larghero, J.; Trinquart, L.; Bruneval, P.; Desnos, M.; Hagège, A.; Pucéat, M.; Menasché, P. Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? Mol. Ther. 17:176-182; 2009.
25. Rehman, J.; Traktuev, D.; Li, J.; Merfeld-Clauss, S.; Temm-Grove, C. J.; Bovenkerk, J. E.; Pell, C. L.; Johnstone, B. H.; Considine, R. V.; March, K. L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298; 2004.
26. Robey, T. E.; Saiget, M. K.; Reinecke, H.; Murry, C. E. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 45:567-581; 2008.
27. Sekine, H.; Shimizu, T.; Kosaka, S.; Kobayashi, E.; Okano, T. Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. J. Heart Lung Transplant. 25:324-332; 2006.
28. Sekine, H.; Shimizu, T.; Okano, T. Myocardial tissue engineering: Toward a bioartificial pump. Cell Tissue Res. 347:775-782; 2012.
29. Stevens, K. R.; Kreutziger, K. L.; Dupras, S. K.; Korte, F. S.; Regnier, M.; Muskheli, V.; Nourse, M. B.; Bendixen, K.; Reinecke, H.; Murry, C. E. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc. Natl. Acad. Sci. USA 106:16568-16573; 2009.
30. Suzuki, K.; Murtuza, B.; Beauchamp, J. R.; Smolenski, R. T.; Varela-Carver, A.; Fukushima, S.; Coppen, S. R.; Partridge, T. A.; Yacoub, M. H. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J. 18:1153-1155; 2004.
31. Winter, E. M.; van Oorschot, A. A. M.; Hogers, B.; van der Graaf, L. M.; Doevendans, P. A.; Poelmann, R. E.; Atsma, D. E.; Gittenberger-de Groot, A. C.; Goumans, M. J. A new direction for cardiac regeneration therapy: Application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Circ. Heart Fail. 2:643-653; 2009.
32. Zhang, F.; Pasumarthi, K. B. S. Embryonic stem cell transplantation: Promise and progress in the treatment of heart disease. BioDrugs 22:361-374; 2008.
33. Zvibel, I.; Smets, F.; Soriano, H. Anoikis: Roadblock to cell transplantation? Cell Transplant. 11:621-630; 2002.